Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Detection of Immune Cell Infiltration Into Melanomas Treated by PV-10, a Feasibility Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01760499
Recruitment Status : Completed
First Posted : January 4, 2013
Last Update Posted : April 19, 2017
Sponsor:
Collaborator:
Provectus Pharmaceuticals
Information provided by (Responsible Party):
H. Lee Moffitt Cancer Center and Research Institute

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : December 29, 2015
Actual Study Completion Date : April 2017